A New Paradigm for Medical Innovation
WHAT IS HEALTH TECHNOLOGY CO-CREATION AND WHY IS IT IMPORTANT?
Traditionally, medical technologies are developed in the lab and introduced to clinics only after years of research. While scientifically rigorous, this approach can sometimes miss key insights from those who will ultimately use these innovations - clinicians and patients.
In recent years, there has been a major shift toward more collaborative models, where scientists, engineers, and healthcare professionals work together from the start to develop solutions that are not only scientifically advanced but also clinically practical and patient-centered.
Engaging clinicians early
incorporating their expertise to refine biomaterials for surgical applications.
Listening to patients
ensuring our materials align with their preferences and expectations.
Iterating continuously
bridging the gap between scientific discovery and real-world medical use.
Insights from Clinicians on Next-Generation Biomaterials
What Surgeons Say About InterLynk
Orthopaedic and maxillofacial surgeons at Charité – Universitätsmedizin Berlin have shared valuable perspectives on InterLynk’s multi-tissue scaffolds, highlighting their potential to reshape complex reconstructive surgeries. Their feedback is actively shaping the development process, ensuring that InterLynk’s biomaterials meet real-world clinical needs.
Key Takeaways from Surgeon Feedback
-
Bridging the Soft-Hard Tissue Gap
"There’s no solution on the market for combining hard and soft tissues seamlessly - this material could fill that gap."
-
Material Synergy for Healing & Strength
"The combination of calcium phosphate and platelet lysates is very interesting - this could be beneficial for several indications, including temporomandibular joint surgery."
-
Precision & Personalization in Surgery
"With 3D printing and CT scans, we could position these implants very precisely - even in delicate areas like facial or joint reconstruction."
Regenerative Medicine, Co-Creation, Clinical Practice
Surgeons Involved in Shaping Next-Generation Regenerative Scaffolds
A survey by InterLynk researchers revealed how surgeons’ clinical practices and openness to innovation can help refine the design of biomaterials - showing majority support for the adoption of InterLynk’s innovative scaffolds and highlighting the value of integrating clinical expertise into development.
Shaping Innovation with Clinical Insight
To bridge the gap between lab and clinic, InterLynk involved oral and maxillofacial surgeons early in the development of its regenerative scaffolds. A dedicated survey revealed that over 60% of respondents are open to try new biomaterials.
Building Trust Through Collaboration
The survey also showed that experienced surgeons value scientific publications and hands-on training when considering new tools. InterLynk’s co-creation model ensures that the project’s innovative solutions align with these priorities.
>60%
>60%
in favour
Ensuring Acceptance and Trust in Biomaterials
PATIENT-CENTERED DESIGN: UNDERSTANDING PREFERENCES FOR BONE HEALING
In parallel with clinician input, InterLynk engaged 198 patients in a survey at Charité to understand their preferences regarding bone replacement materials.
Trust in Natural Materials
Patients preferred biomaterials derived from their own bodies.
Desire for Resorbable Solutions
Many expressed a clear preference for biodegradable implants that dissolve once healing is complete, instead of permanent implants.
Concerns About Foreign Implants
Some patients voiced hesitations about synthetic materials, emphasizing the need for transparency and education on safety and long-term effects.
Building a Future with Stakeholder-Led Innovation
BEYOND THE LAB: CO-CREATION IN ACTION
In addition to direct clinician and patient engagement, InterLynk is continuously exploring new ways to integrate real-world feedback. Potential third co-creation activity examples include:
1
Regulatory & Market Feasibility Studies
Collaborating with industry partners to align biomaterial development with regulatory pathways, ensuring smoother clinical translation.
2
Clinician-Researcher Workshops
Hosting iterative workshops where scientists, engineers, and medical professionals co-develop solutions, refining materials before clinical trials.
3
Digital Simulation & AI Integration
Leveraging computational models to predict biomaterial performance under various patient conditions, fine-tuning design parameters before fabrication.
